Overview

Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty

Status:
Completed
Trial end date:
2017-02-08
Target enrollment:
Participant gender:
Summary
This is a Phase 4, multicenter, randomized, double-blind, controlled trial in approximately 140 adult subjects undergoing primary unilateral TKA under spinal anesthesia with bupivacaine HCl (10-15 mg).
Phase:
Phase 4
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc
Treatments:
Bupivacaine